tiprankstipranks
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
Holding SNSE?
Track your performance easily

Sensei Biotherapeutics (SNSE) Financial Statements

181 Followers

Sensei Biotherapeutics Financial Overview

Sensei Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.188; its P/E ratio is -0.44; Sensei Biotherapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue--$ 94.00K$ 276.00K-
Gross Profit--$ 94.00K$ 276.00K-
EBIT$ -7.23M$ -7.12M$ -3.05M-$ -7.09M
EBITDA$ -6.51M$ -6.40M$ -2.35M-$ -6.76M
Net Income Common Stockholders$ -7.25M$ -7.14M$ -7.99M$ -7.41M$ -7.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 47.00M$ 52.29M$ 58.08M$ 65.76M$ 72.01M
Total Assets$ 53.25M$ 59.80M$ 66.69M$ 74.37M$ 81.66M
Total Debt$ 4.47M$ 5.05M$ 5.64M$ 6.21M$ 6.77M
Net Debt$ -42.53M$ -47.24M$ -52.44M$ -59.55M$ -65.24M
Total Liabilities$ 7.47M$ 7.61M$ 8.22M$ 9.48M$ 10.66M
Stockholders Equity$ 45.78M$ 52.19M$ 58.47M$ 64.89M$ 71.00M
Cash Flow-
Free Cash Flow$ -5.47M$ -5.90M$ -7.65M-$ -4.66M
Operating Cash Flow$ -5.47M$ -5.79M$ -7.62M$ -6.16M$ -4.66M
Investing Cash Flow$ 12.91M$ 6.91M$ 5.77M$ 8.26M$ 8.31M
Financing Cash Flow$ -204.00K$ -180.00K$ -209.00K$ -431.00K$ -2.53M
Currency in USD

Sensei Biotherapeutics Earnings and Revenue History

Sensei Biotherapeutics Debt to Assets

Sensei Biotherapeutics Cash Flow

Sensei Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis